| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.04 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.04 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.04 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.04 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |